Cloverfields Capital Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.44M Sell
61,769
-804
-1% -$61.9K 1.44% 31
2025
Q4
$4.97M Buy
62,573
+5,723
+10% +$451K 1.54% 28
2025
Q3
$4.29M Buy
56,850
+104
+0.2% +$7.13K 1.34% 31
2025
Q2
$3.91M Buy
56,746
+11,621
+26% +$762K 1.16% 37
2025
Q1
$3.06M Buy
+45,125
New +$2.7M 1.01% 41

Other funds holding CVS

Cloverfields Capital Group's CVS Position: Q1 2026 in Review

Cloverfields Capital Group reduced its CVS Health (CVS) stake by 1.3% in Q1 2026, selling an estimated $61.9K and leaving 61,769 shares worth $4.44M. The position accounts for 1.44% of the portfolio, ranked #31.

Cloverfields Capital Group first reported a position in CVS in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.97M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Cloverfields Capital Group held 61,769 shares of CVS Health worth $4.44M as of Q1 2026.
  • Cloverfields Capital Group sold 804 CVS Health shares in Q1 2026, an estimated $61.9K.
  • CVS Health made up 1.44% of Cloverfields Capital Group's portfolio in Q1 2026, its #31 holding.
  • Cloverfields Capital Group first reported a position in CVS Health in Q1 2025 and has held it in 5 quarters since.
  • Cloverfields Capital Group's CVS Health position peaked at $4.97M in Q4 2025.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Cloverfields Capital Group's 13F filing for Q1 2026, filed 14 May 2026.